SOLVO Biotechnology has been the pioneer and leader in the commercialization of membrane transporter technologies, diagnostics and drug discovery assays. SOLVO Biotechnology has outstanding knowledge on transporters, the widest drug-transporter assay portfolio and the largest R&D Department among its competitors. SOLVO continuously expands its product and service portfolio (with 10-15 new launches annually), based on the latest results in transporter science, the needs of the pharmaceutical industry and the various regulatory agencies such as FDA and EMA. SOLVO’s mainstream products and services are in vitro and in vivo assay systems to detect the interaction of test compounds with a wide array of ABC and SLC Transporter proteins for ADME/Tox research. All major pharma and biotech companies use SOLVO’s assays, either in-house or as contract research.